Streetbeat News

Analyst Ratings

NKE

Nike's stock is experiencing an uptick following Guggenheim's reaffirmation of a Buy rating and a $130 price target for the company.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 7:39 pm

NKE

Guggenheim analyst Robert Drbul maintains a Buy rating on Nike (NKE) and sets a price target of $130.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 7:35 pm

EL

Estee Lauder Cos (NYSE:EL) has seen unusual options activity, with a mix of bullish and bearish sentiments among big-money traders. The options scanner revealed 10 uncommon trades, split evenly between bullish and bearish, targeting a price range of $135.0 to $220.0. Notable trades include both calls and puts with significant total trade prices. Estee Lauder, a leader in the global prestige beauty market, has a current stock price of $150.02, with an RSI indicating a neutral position. Analyst ratings in the last month have an average target price of $167.67, with mixed revisions.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 7:30 pm

TSLA

Aswath Damodaran, a prominent finance professor, recently purchased Tesla Inc (NASDAQ:TSLA) stock at $180, sparking discussions among investors on Reddit's r/ValueInvesting about Tesla's valuation. While some Redditors see Damodaran's purchase as timely, citing his expertise in valuation and Tesla's diversified offerings, others express caution due to concerns over Tesla's P/E ratio, economic challenges in China, and uncertainties around Model 3 refresh qualifications for tax credits. Technical analysis suggests potential support for Tesla's stock at $160.

Portfolio Pulse from Surbhi Jain

March 11, 2024 | 7:27 pm

ASLN

ASLAN Pharmaceuticals shares are trading higher following bullish comments from Piper Sandler.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 7:16 pm

WBA

Financial giants have shown a bearish sentiment towards Walgreens Boots Alliance (WBA), with options trading indicating a price target range of $15.0 to $27.5. Analysis of unusual trades shows a mix of bullish and bearish tendencies among traders, with a significant volume in puts. Walgreens, a major retail pharmacy chain in the U.S., is approaching its earnings announcement with its stock price slightly down and an RSI indicating it may be nearing overbought. Analyst ratings in the last month have downgraded WBA with target prices between $20 and $23.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 7:16 pm

NFLX

Financial analysis reveals a bearish sentiment in Netflix's (NASDAQ:NFLX) options market, with 67% of trades showing bearish tendencies. The analysis highlighted unusual trading activity, including 143 trades with a focus on a price band between $40.0 and $1000.0. The largest trades included both bearish and bullish sentiments, with significant activity around the $290.00 strike price. Netflix, with its vast subscriber base and recent move into ad-supported plans, is currently trading up by 0.54% at $608.08, with analysts setting an average price target of $705.0.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 7:15 pm

ASLN

Piper Sandler analyst Edward Tenthoff has maintained an Overweight rating on ASLAN Pharma (NASDAQ:ASLN) with a price target of $15.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 7:01 pm

LLY

Eli Lilly and Co (NYSE:LLY) has seen a bearish trend in options trading, with 69% of investors holding bearish expectations. The trading activity suggests a price target range of $390 to $1080. Significant trades include both bullish and bearish sentiments, with notable trades aiming for strike prices between $600 and $770. The company's stock price is currently down by -1.33% at $752, with neutral RSI indicators. Analysts have set an average target price of $880, with ratings ranging from Overweight to Hold.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 7:01 pm

CELH

CVNA

MNST

MTUM

SF

SMCI

Celsius Holdings (NASDAQ:CELH) stock fell over 6% amid a broader sell-off in momentum stocks, despite a bullish analyst rating from Stifel Financial Corp (NYSE:SF) with a price target increase from $90 to $95. Other momentum stocks like Monster Beverage Corp (NASDAQ:MNST), Carvana Co (NYSE:CVNA), and Super Micro Computer Inc (NASDAQ:SMCI) also experienced declines. The iShares MSCI USA Momentum Factor ETF (BATS:MTUM) dropped more than 1%, indicating a potential slowdown in the momentum stock trend.

Portfolio Pulse from Aaron Bry

March 11, 2024 | 6:51 pm